Bayer plans 3 new drugs, banks on gene and cell therapy allogeneic cancer medicines
German pharma giant Bayer has plans to introduce three news drugs with annual sales potential of $1.22 billion (€1 billion) but these will not offset the fall in revenue the comp
Germany's CureVac announces phase 2b/3 COVID vaccine trial
Get the latest COVID vaccine news and updates here at the nation’s fastest-growing CEO magazine, Industry Leaders.
